• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Tissue Regeneration

Organovo inks L’Oreal deal for 3d-printed skin

May 7, 2015 By Mark Hollmer Leave a Comment

Organovo inks L'Oreal deal for 3d-printed skin

Filed Under: Biotech, News Well Tagged With: 3D printing, L'Oreal, Organovo, Tissue Regeneration

First successful lab-grown vaginas herald disruptive innovation on the horizon

April 11, 2014 By Arezu Sarvestani

First successful lab-grown vaginas herald disruptive innovation on the horizon

A team of researchers successfully implanted 4 young women with laboratory grown vaginas for the first time, representing an important breakthrough in regenerative medicine.

Filed Under: News Well, Regenerative Medicine, Research & Development, Women's Health Tagged With: Clinical Trials, Tissue Regeneration, Wake Forest University

Shire ditches troubled Dermagraft skin substitute

January 20, 2014 By Arezu Sarvestani Leave a Comment

Shire ditches troubled Dermagraft skin substitute

Regenerative therapies maker Shire (NSDQ:SHPGY) announced that it sold its troubled Dermagraft business to Organogenesis in a deal worth up to $300 million in sales-based milestone payments.

Filed Under: Mergers & Acquisitions, News Well, Regenerative Medicine Tagged With: Organogenesis Inc., Shire Plc., Tissue Regeneration

Soft Tissue Regeneration raises $4.7M for biodegradable scaffold

December 9, 2013 By Arezu Sarvestani Leave a Comment

Soft Tissue Regeneration raises $4.7M for biodegradable scaffold

Orthopedics maker Soft Tissue Regeneration is closing in on a $5 million funding round, with $4.7 million raised so far.

The New Haven, Conn.-based company is raising funds through sales of equity, options, warrants and other securities, with 14 unnamed investors listed so far in regulatory filings.

Filed Under: Funding Roundup, News Well, Regenerative Medicine Tagged With: Soft Tissue Regeneration, Tissue Regeneration

World’s 1st regenerated trachea recipient faring well at 5 years

October 24, 2013 By Arezu Sarvestani Leave a Comment

World's 1st regenerated trachea recipient faring well at 5 years, Harvard Bioscience says

Filed Under: News Well, Regenerative Medicine, Research & Development Tagged With: Harvard Apparatus Regenerative Technology (HART), Harvard Bioscience Inc., Organ Transplant, Tissue Regeneration

TissueTech fleshes out $10M equity round

August 22, 2013 By Brad Perriello Leave a Comment

TissueTech fleshes out $10M equity round

TissueTech Inc. said it pulled down $10 million from a pair of venture capital shops to back its regenerative medicine subsidiaries, Bio-Tissue and Amniox Medical.

The equity round came from Ballast Point Ventures and River Cities Capital Funds, according to a press release.

Doral, Fla.-based TissueTech makes amniotic membrane- and umbilical cord-based products designed to treat ocular surface diseases (Bio-Tissue) and musculoskeletal conditions and wound care (Amniox Medical), according to the release.

Filed Under: Funding Roundup, News Well, Regenerative Medicine, Wall Street Beat Tagged With: Amniox Medical, Bio-Tissue Inc., Tissue Regeneration, Tissuetech, Venture Capital/Private Equity

Shire expands regenerative medicine biz with Lotus Tissue Repair acquisition

January 10, 2013 By MassDevice staff Leave a Comment

Shire

Shire (NSDQ:SHPGY) said it aquired Cambridge, Mass.-based Lotus Tissue Repair, which is developing the 1st protein replacement therapy to treat dystrophic epidermolysis bullosa, a rare genetic disease.

The purchase includes an upfront payment and later milestone payments, but specific details were not released.

Filed Under: Mergers & Acquisitions, News Well, Regenerative Medicine Tagged With: Advanced BioHealing Inc., Lotus Tissue Repair, Shire Plc., Tissue Regeneration

Soft Tissue Regeneration receives FDA clearance for its rotator cuff repair device

January 7, 2013 By MassDevice staff Leave a Comment

Soft Tissue Regeneration, an early stage orthopedic device maker, has received FDA clearance for its Str graft, a biodegradable scaffold that can lessen patient’s pain and reduce surgical failure rates following rotator cuff surgery.

The Str graft, a 3-dimensional braided "patch," is about 1 millimeter. Surgeons using the device drape it over the tendon with sutures to help the tendon, bones and nearby tissues heal.

Sign up to get our free newsletters delivered right to your inbox.

[sead]

Filed Under: News Well Tagged With: Soft Tissue Regeneration, Tissue Regeneration

Shire wins DermaGraft nod in Canada

September 5, 2012 By MassDevice staff Leave a Comment

Shire

Regulators north of the border gave Shire (NSDQ:SHPGY) its first approval outside of the U.S. for the DermaGraft regenerative skin patch it bought when it acquired Advanced BioHealing last year.

Filed Under: News Well, Regenerative Medicine Tagged With: Health Canada, Shire Plc., Tissue Regeneration

Top 10 science and clinical innovation trends: Looking forward to 2012

January 6, 2012 By MassDevice Contributors Network Leave a Comment

DNA with legos
(Michael Knowles/Flickr)

By Nancy Fliesler

Here once again is Vector’s take on some exciting trends we’ve been watching in the pediatric health arena and what we expect to see more of this year. If you’ve got others to propose, scroll to the bottom and let us know!

Filed Under: Health Information Technology, Healthcare Reform, News Well, Pharmaceutical, Regenerative Medicine, Research & Development Tagged With: Boston Children's Hospital, Remote Patient Monitoring, Tissue Regeneration

MassDevice.com +3 | Weight loss: FDA warns Lap-Band advertisers, MDT to pay $23.5M to settle kickback claims, Baxter inks $325M buyout pact with Synovis

December 13, 2011 By MassDevice staff Leave a Comment

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you’re still in the know with MassDevice +3.

Filed Under: Cardiac Implants, Food & Drug Administration (FDA), Implants, Legal News, Mergers & Acquisitions, News Well, Spine Tagged With: Allergan, Baxter, Clinical Trials, Gastrointestinal, Synovis Life Technologies Inc., Tissue Regeneration, U.S. Justice Dept. (DOJ)

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 5
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy